Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base.
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base.
Medicine Products:(Date:12/2/2008)...ss people in Western countries have substantially ...neral population, according to results from a syst... Medicine this week. , Searching for studies ov...evalence of mental disorders in homeless people, S...ord identified 29 studies involving 5,684 homeless...
(Date:12/2/2008)...are large health differences between groups of imm...ferences are also great. The differences are seen ...n in a new report from the Norwegian Institute of ...s were compared with each other and the ethnic Nor...order to target health care better. , The five ...
(Date:12/2/2008)... given Trasylol have a higher death risk, data rev... News) -- A new study casts more doubt on the saf...t bleeding in patients undergoing surgery. , Tr...e United States, where it was removed from the mar...ustralian researchers reviewed findings from 49 ra...
(Date:12/2/2008)...RG, Pa., Dec. 2 Are you...etic, corrective options are available? , , ... consumers that many cosmetic options exist to imp...s, wishes and dental history to determine a suitab... a summary of many cosmetic dental options. , ...
Breaking Medicine News(10 mins):Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Cosmetic Dentistry: A Beautiful Smile Is Not Far Away 2(Date:12/1/2008)...-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq:... of the world,s leading medical journals, results ...r, experimental compound tasimelteon (VEC-162). T..."Melatonin agonist tasimelteon (VEC-162) for trans...ed controlled multicentre trials." Results are rep...
(Date:12/1/2008)...-- Roche announced today that a,comparative study...in and,discomfort associated with blood glucose t...systems and lancing devices were deemed least pain... ACCU-CHEK Aviva and ACCU-CHEK Compact,Plus blood...iclix, ACCU-CHEK,Softclix and ACCU-CHEK Softclix ...
(Date:12/1/2008)... policy , , ROCHESTER, Minn., Dec. 1 /PRNe... finds the use of the drug therapy etanercept inef...inflammation of the liver caused by excessive cons...ublished in the December issue of Gastroenterolog...VIDEO ALERT: Additional audio and video resources,...
(Date:12/1/2008)...uesday, December 9 at 11:00 am ET to Discuss Phase...RANCISCO, Calif., Dec. 1 /PRNewswire-FirstCall/ ..., a biopharmaceutical company focused on the devel...peutics, today announced new data from its studies... be presented during the 50th American Society of ...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 2Study Shows ACCU-CHEK(R) Blood Glucose Monitoring Systems and Lancing Devices Are Least Painful 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Balloon Valve May Be Alternative to Open Heart Surgery 5437 1Balloon Valve May Be Alternative to Open Heart Surgery 5437 2Balloon Valve May Be Alternative to Open Heart Surgery 5437 3No increase in cardiovascular risk for living kidney donors 5433 1No increase in cardiovascular risk for living kidney donors 5433 2Healthcare Workers Community Activists Call for Fair Election Agreement at St Joseph Health System 5429 1Healthcare Workers Community Activists Call for Fair Election Agreement at St Joseph Health System 5429 2Emergency Care for Heart Attacks Pneumonia Fails to Meet Goals 5425 1Emergency Care for Heart Attacks Pneumonia Fails to Meet Goals 5425 2...pen-Label Study Presented at Federation of,Clinica...ARLSBAD, Calif., June 11, 2007 /PRNewswire-FirstCa...d: OCHT) announced today,positive new data from it...TM), an investigational T Cell Receptor (TCR) pept...ng multiple sclerosis,(MS). The new data, presente...
... Phase 1 Clinical Trial of SNS-595 in Acute,Leukem...H SAN FRANCISCO, Calif., June 11, 2007,/PRNewswire...nted,positive data from clinical studies of two of...-595 and SNS-032, at the 12th,Congress of the Euro...ia. , Interim Results from Sunesis, Phase 1 Study ...
Other Medicine Technology:Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 2Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 3Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 4Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 5Sunesis Pharmaceuticals Reports Positive Data From Studies of Two,Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of,the European Hematology Association 6